Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Pancreatic Inflammation & Potential Pancreatic Damage While GLP-1 receptor agonists (e.g., Ozempic, Wegovy, Mounjaro) are widely used and carry established warnings for acute pancreatitis, extensive large-scale studies show the overall absolute risk remains very low, and long-term data indicates they do not increase the lifetime risk of pancreatic damage for most patients Pancreatitis is a known risk of GLP-1 drugs, but long-term consequences are still being studied
our ability to develop and commercialize additional pharmaceutical products
Our minimum order quantity (MOQ) is 15,000 sticks for stock formulas
PlexusDx serves all 50 states without insurance requirements, and treatment is HSA- and FSA-eligible, making long-term personalized GLP-1 therapy accessible regardless of employment status
What the Current Clinical Evidence Shows Phase 2 trial data published in the NEJM in 2023 show gastrointestinal events including nausea were the most common side effects, were transient and self-limiting in most participants, and were more frequent at higher doses
It plays a crucial role in regulating appetite and glucose metabolism
US$ 21.81
US$ 25.70
US$ 22.94
US$ 22.96
